ReviewCurrent obesity reports2026
Treatment Decision-making and Weight Loss Expectations for Current Obesity Treatment.
Review in Current obesity reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewThe objective of this review is to provide a framework for shared decision making for the treatment of obesity. RECENT
findingsObesity is a chronic medical condition with increasing prevalence. Current treatment includes intensive lifestyle change, medical therapy, and bariatric surgery. Incretin based medical therapy now offers efficacy that is approaching that of bariatric surgery (15-20%). However, challenges persist with underutilization of therapy and need for appropriate treatment selection. This review aims to explore how patient and provider expectations, along with behavioral, biological, and socioeconomic factors, influence obesity treatment decisions. WHAT'S THE IMPACT ON FUTURE RESEARCH?: The landscape for obesity management is rapidly changing as new therapies emerge, and more long-term data becomes available for existing therapies. There is growing interest in characterizing obesity genotypes and phenotypes to address the heterogeneous treatment response. The goal is to develop a model of care that individualizes obesity treatment.
Indexed as
Identifiers
41758396What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.